To identify oseltamivir resistance, we analyzed neuraminidase H275Y mutations in samples from 10 patients infected with pandemic (H1N1) 2009 virus in South Korea who had influenza that was refractory to antiviral treatment with this drug. A neuraminidase I117M mutation that might influence oseltamivir susceptibility was detected in sequential specimens from 1 patient
Enhanced surveillance of infections due to the pandemic A(H1N1) influenza virus, which included moni...
Neuraminidase inhibitors (NAIs) oseltamivir and zanamivir are currently the only effective antiviral...
Enhanced surveillance of infections due to the pandemic A(H1N1) influenza virus, which included moni...
Resistance to oseltamivir was observed in influenza A pandemic (H1N1) 2009 virus isolated from an un...
Eleven patients with drug-resistant pandemic (H1N1) 2009 were identified in South Korea during May 2...
Analysis of mutations I117V and I117M in the neuraminidase of influenza A pandemic (H1N1) 2009 virus...
In the treatment of influenza, Neuraminidase inhibitors (NAIs) (Oseltamivir and Zanamivir) play a ma...
To monitor and characterize oseltamivir-resistant (OR) pandemic (H1N1) 2009 virus with the H275Y mut...
Background: Resistance of pandemic A(H1N1)2009 (H1N1pdm09) virus to neuraminidase inhibitors (NAIs) ...
BACKGROUND: Resistance of pandemic A(H1N1)2009 (H1N1pdm09) virus to neuraminidase inhibitors (NAIs) ...
Resistance of pandemic A(H1N1)2009 (H1N1pdm09) virus to neuraminidase inhibitors (NAIs) has remained...
Analysis of mutations I117V and I117M in the neuraminidase of influenza A pandemic (H1N1) 2009 virus...
During May 2009–April 2010, we analyzed 692 samples of pandemic (H1N1) 2009 virus from patients in M...
The H275Y oseltamivir resistance mutation confers high-level resistance to oseltamivir in isolates o...
The clinical use of the neuraminidase inhibitor (NAI) oseltamivir is associated with the emergence o...
Enhanced surveillance of infections due to the pandemic A(H1N1) influenza virus, which included moni...
Neuraminidase inhibitors (NAIs) oseltamivir and zanamivir are currently the only effective antiviral...
Enhanced surveillance of infections due to the pandemic A(H1N1) influenza virus, which included moni...
Resistance to oseltamivir was observed in influenza A pandemic (H1N1) 2009 virus isolated from an un...
Eleven patients with drug-resistant pandemic (H1N1) 2009 were identified in South Korea during May 2...
Analysis of mutations I117V and I117M in the neuraminidase of influenza A pandemic (H1N1) 2009 virus...
In the treatment of influenza, Neuraminidase inhibitors (NAIs) (Oseltamivir and Zanamivir) play a ma...
To monitor and characterize oseltamivir-resistant (OR) pandemic (H1N1) 2009 virus with the H275Y mut...
Background: Resistance of pandemic A(H1N1)2009 (H1N1pdm09) virus to neuraminidase inhibitors (NAIs) ...
BACKGROUND: Resistance of pandemic A(H1N1)2009 (H1N1pdm09) virus to neuraminidase inhibitors (NAIs) ...
Resistance of pandemic A(H1N1)2009 (H1N1pdm09) virus to neuraminidase inhibitors (NAIs) has remained...
Analysis of mutations I117V and I117M in the neuraminidase of influenza A pandemic (H1N1) 2009 virus...
During May 2009–April 2010, we analyzed 692 samples of pandemic (H1N1) 2009 virus from patients in M...
The H275Y oseltamivir resistance mutation confers high-level resistance to oseltamivir in isolates o...
The clinical use of the neuraminidase inhibitor (NAI) oseltamivir is associated with the emergence o...
Enhanced surveillance of infections due to the pandemic A(H1N1) influenza virus, which included moni...
Neuraminidase inhibitors (NAIs) oseltamivir and zanamivir are currently the only effective antiviral...
Enhanced surveillance of infections due to the pandemic A(H1N1) influenza virus, which included moni...